Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Combined Effects of Drugs: Antagonism

Combined Effects of Drugs: Antagonism

The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...

Combined Effects of Drugs: Synergism

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...

Pharmacokinetics: Drug–Drug Interactions

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

Drug toxicity: Drug–Drug Interaction

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Impact of Hydrocodone Rescheduling on Dental Prescribing of Opioids.

JDR clinical and translational research·2022

Same author

Distribution of Isolates of Sclerotium rolfsii Tolerant to Pentachloronitrobenzene in Texas Peanut Fields.

Plant disease·2019

Same author

An evaluation of the potential drug interaction between warfarin and levothyroxine.

Journal of thrombosis and haemostasis : JTH·2014

Same author

Prioritizing comparative-effectiveness research topics via stakeholder involvement: an application in COPD.

Clinical pharmacology and therapeutics·2011

Same author

Skeletal health in men with chronic lung disease: rates of testing, treatment, and fractures.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2010

Same author

Present and future costs of COPD in Iceland and Norway: results from the BOLD study.

The European respiratory journal·2009

Search research articles

Related Experiment Video

Updated: Jul 23, 2026

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

High-throughput Identification of Synergistic Drug Combinations by the Overlap² Method

Published on: May 21, 2018

Performance of community pharmacy drug interaction software.

T K Hazlet¹, T A Lee, P D Hansten

¹Department of Pharmacy, School of Pharmacy, University of Washington, Seattle 98195-7630, USA. thazlet@u.washington.edu

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)

|April 12, 2001

Summary

Computerized drug-drug interaction (DDI) software often fails to detect clinically significant interactions, missing one-third of cases. Further improvements are crucial for enhancing patient safety through accurate DDI detection.

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Related Experiment Videos

Last Updated: Jul 23, 2026

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

High-throughput Identification of Synergistic Drug Combinations by the Overlap² Method

Published on: May 21, 2018

Diagonal Method to Measure Synergy Among Any Number of Drugs

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Area of Science:

Pharmacology
Health Informatics
Clinical Pharmacy

Background:

Computerized drug-drug interaction (DDI) software is widely used in clinical practice to prevent adverse drug events.
The effectiveness of these software systems in identifying clinically significant DDIs requires ongoing evaluation.

Purpose of the Study:

To assess the performance of various computerized DDI software programs in detecting important drug-drug interactions.
To quantify the accuracy of DDI software using key performance metrics.

Main Methods:

A one-time performance test was conducted using a standardized set of prescriptions.
Nine different DDI software programs were evaluated across 516 community pharmacies.
The study measured sensitivity, specificity, and predictive values for detecting 16 known DDIs in fictitious patient profiles.

Main Results:

The evaluated DDI software failed to detect clinically relevant interactions in approximately one-third of instances.
Software sensitivity ranged from 0.44 to 0.88, indicating suboptimal performance in some cases.
Variability in performance was observed between different installations of the same software packages.

Conclusions:

The performance of most tested DDI-detecting software was suboptimal.
Enhancements are necessary to improve the reliability and clinical utility of DDI software.
Better DDI detection is essential for improving patient safety and medication management.